文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

一氧化碳释放分子-3减轻失血性休克复苏后急性肺损伤:p38MAPK信号通路的作用

Carbon Monoxide-Releasing Molecule-3 Ameliorates Acute Lung Injury in a Model of Hemorrhagic Shock and Resuscitation: Roles of p38MAPK Signaling Pathway.
PubMed 文献 · Shock · 2021-01-01
一句话结论大鼠失血性休克复苏后给予CORM-3可减轻急性肺损伤,其机制可能与抑制肺巨噬细胞p38MAPK信号通路有关。

结果显示HSR后B线评分、肺损伤评分和湿/干重比升高,CORM-3给药显著降低上述指标及凋亡和焦亡巨噬细胞数量、p-p38MAPK表达。p-p38MAPK特异性抑制剂SB203580(5 mg/kg腹腔注射)不仅减轻HSR诱导的肺损伤,还增强CORM-3的保护作用。结论提示CORM-3对HSR诱导的急性肺损伤有保护作用,机制可能与抑制肺巨噬细胞p38MAPK信号通路有关。

要点

  • 大鼠失血性休克模型:放血至平均动脉压30 mm Hg维持45分钟,经左静脉回输自体血复苏。
  • CORM-3还显著减少凋亡和焦亡巨噬细胞数量及p-p38MAPK表达。
  • p-p38MAPK抑制剂SB203580(5 mg/kg腹腔注射)减轻HSR诱导肺损伤,并增强CORM-3的保护效应。
  • 上述结果为动物实验,CORM-3尚未在临床急诊/ICU患者中验证。

适用人群与场景

  • 大鼠失血性休克复苏模型:放血至平均动脉压30 mm Hg并维持45分钟,随后经左静脉回输自体血复苏。

诊断标准与关键阈值

  • 原文未提及临床诊断标准或启动/停止阈值;动物模型中肺损伤以B线评分、肺损伤评分和湿/干重比升高判定。

处置流程与药物剂量

  • 动物实验方案:HSR后给予CORM-3 4 mg/kg或8 mg/kg(原文未注明给药途径与频次)。
  • 动物实验方案:SB203580 5 mg/kg经腹腔给药(原文未注明频次与疗程)。
  • 原文未提及临床患者的药物剂量、给药途径或目标值。

红旗征与不能漏的情况

  • 原文未提及临床红旗征或需立即处理的情况。

研究设计与关键结果

  • 研究类型:动物实验(大鼠),样本量原文未提及。
  • CORM-3给药显著降低B线评分、肺损伤评分、湿/干重比、凋亡和焦亡巨噬细胞数量及p-p38MAPK表达(原文未给出具体数值与P值)。
  • SB203580不仅减轻HSR诱导的肺损伤,还增强CORM-3的抗肺损伤作用。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠模型)。
  • 原文未述局限性。

对床旁实践的改变

  • 该内容为动物实验机制研究,尚不能直接改变急诊/ICU对失血性休克复苏后急性肺损伤的临床处置。
  • 原文未提及适用与不适用人群及常见陷阱。

指南或共识出处

  • 原文未提及指南或共识出处;文献来源为Shock期刊。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: It was reported that carbon monoxide-releasing molecule-3 (CORM-3) administration immediately after hemorrhagic shock and resuscitation (HSR) ameliorates the HSR-induced acute lung injury (ALI); however, the specific mechanism of the protective effects against HSR-induced ALI remains unclear.

METHODS: To induce hemorrhagic shock, rats were bled to a mean arterial blood pressure of 30 mm Hg for 45 min and then resuscitated with shed blood via the left vein. CORM-3 (4 mg/kg or 8 mg/kg) was respectively administrated after HSR. Twelve hours post-HSR, lung injury was assessed by wet/dry (W/D) ratio, hematoxylin-eosin staining staining, and lung ultrasound; the apoptotic and pyroptotic macrophages were measured by immunofluorescence staining; and the expression of phosphorylated p38 mitogen activated protein kinase (p-p38MAPK) and total p38MAPK was measured by western blotting. SB203580 (5 mg/kg), a special inhibitor of p-p38MAPK, was administrated by abdominal cavity to assess the roles of p38MAPK in HSR-induced ALI.

RESULTS: Increased B-line score, lung injury score, and W/D ratio indicated the fact of ALI after HSR. Twelve hours post-HSR, CORM-3 administration significantly decreased the B-line score, lung injury score, W/D ratio, apoptotic and pyroptotic macrophages, and the expressions of p-p38MAPK. Further, SB203580 not only reduced HSR-induced ALI, but also enhanced the protective effects of CORM-3 against ALI.

CONCLUSION: We identified the protective effects of CORM-3 against HSR-induced ALI. The mechanism might be related to the inhibition of p38MAPK signaling pathway in lung macrophages.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Bai J, Bai Y, Wang XP, et al. Carbon Monoxide-Releasing Molecule-3 Ameliorates Acute Lung Injury in a Model of Hemorrhagic Shock and Resuscitation: Roles of p38MAPK Signaling Pathway. Shock. 2021. PMID: 33105439. doi:10.1097/SHK.0000000000001684

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。